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It has been shown that specific immune resp6nse (Ir)  genes within the I region of 
the  major histocompatibility complex  (MHC) 1 of mammals play a  major role in 
thymus dependent immune responses (1, 2). However, the mechanism of the expression 
of Ir gene function remains an area of intense research and great speculation. Over 
the  years,  an  attractive  hypothesis has  emerged  that  suggests  that  the  antigenic 
determinants involved in stimulating primed helper, delayed-type hypersensitivity, or 
proliferative T  cell clones are a complex of antigen fragments in association with the 
glycoprotein alloantigens--the immune response-associated (Ia)  molecules (3). This 
functional complex of nomimal antigen and Ia is suitably displayed to T  cells by 
antigen-presenting cells of variable origin, including those of mononuclear phagocyte 
(M~) lineage (4). To date, the information suggesting that Ia molecules are directly 
involved in Ir gene function has only been inferential; proof of such linkage would 
require experiments demonstrating the actual physicochemical association of antigen 
with Ia. 
Previous work with defined protein antigens such as insulin has contributed much 
to our present understanding of the nature and mechanism of Ir gene function in 
antigen recognition (5-8). For example, MHC-linked Ir genes control the murine T 
cell proliferative response of H-2  b mice to beef insulin (9). This control is dependent 
on a determinant selection process expressed by the Ia-positive antigen-presenting Mq~ 
and maps to the K b and/or LA  b subregion(s) of the H-2 gene complex. 
Recently, Ia.W39, a  new private specificity of I-A  b, has been described (10).  It is 
selectively expressed on a  functional subset of B cells, which is absent  in newborn 
normal  and  adult  mutant  mice carrying the xid gene.  Furthermore,  the molecule 
bearing this Ia specificity is synthesized in the cytoplasm of B cells in xid-defective 
and neonatal normal mice, although it  is not expressed  on  the B  cell membrane. 
Biochemical studies have revealed that Ia.W39 has a similar two-chain structure and 
two-dimensional gel pattern as the conventional Ia molecule, suggesting that In.W39 
is  a  conformational  specificity,  expressed  on  a  subset  of molecules  bearing  the 
conventional Ia antigens.  2 This Ia molecule with its unique specificity and selective 
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expression  represents  a  potentially  powerful  probe  in  the  dissection  of the  specific 
mechanism of Ir gene function for beef insulin in the H-2  b mouse. 
The  experiments  described  in  this  report  examine  the  role  of Ia.W39  in  the 
activation  of insulin-specific  H-2  b T  cells.  They suggest  that  beef insulin  related  Ir 
gene function is dependent upon the expression of this Ia molecule at the level of the 
antigen-presenting Mq~. Furthermore, it is demonstrated for the first time that a non- 
MHC  gene  (xid) controls the optimal expression  and execution of Ir gene function, 
possibly  by  regulating  the  membrane  expression  of an  Ia  molecule  (Ia.W39)  on 
antigen-presenting cells. 
Materials and Methods 
Animals.  C57BL6/J (B6) and (C57BL6/J ×  DBA2/J)F1 (BDF  0 mice were purchased from 
The Jackson  Laboratory,  Bar  Harbor,  Maine.  (CBA/N  ×  C57BL6)FI  [(N  ×  B6)F1] and 
(C57BL6 × CBA/N)Ft [(B6 ×  N)FI] mice were bred in the animal facilities  at Tufts University 
School of Medicine, Boston, Mass. from breeding stock originally obtained from the National 
Institutes of Health, Bethesda, Md. 
Antigens.  Beef and pork insulin were obtained from Eli Lilly and Co., Indianapolis, Ind. 
and were the kind gifts of Dr. Alan S. Rosenthal of Merck, Sharp and Dohme, Rahway, N. J. 
Both beef and pork insulin contained <0.05% of proinsulin contamination. Ovalbumin five- 
times recrystallized (Sigma Chemical Co., St. Louis, Mo.), was coupled with 2,4,6-trinitroben- 
zene sulfonate  (Pierce Chemical Co.,  Rockford, Ill.)  as described elsewhere  (11) to prepare 
trinitrophenylated  ovalbumin  (TNP-OVA). Purified protein derivative of tuberculin  (PPD) 
was  obtained  from  Connaught  Medical  Research  Laboratory, Toronto,  Ontario,  Canada. 
Phytohemagglutinin (PHA) was obtained from Burroughs Wellcome Co., Research Triangle 
Park, N. C. 
Immunization.  Mice were immunized by injections of 0.05 ml in each hind footpad of an 
emulsion of antigen and complete Freund's adjuvant  (CFA) containing 0.5 mg/ml of killed 
Mycobacterium tuberculosis (Grand Island Biological Co., Grand Island, N. Y.).  50 #g of beef or 
pork insulin and  10 #g of TNP-OVA were present  in 0.1  ml of emulsion. In some instances, 
mice were boosted with equivalent amounts of  antigen in CFA 14 d after primary immunization. 
Cell Culture Techniques.  The technique used for antigen-induced T  cell proliferation repre- 
sents a modification of previously described and well-characterized assays (9,  12). All washing 
procedures were performed in Hanks' balanced salt solution (HBSS; Grand Island Biological 
Co.) and cells were cultured in RPMI-1640 (Grand Island Biological Co.), supplemented with 
fresh L-glutamine (0.3 mg/ml), penicillin (100 #/ml), and streptomycin (100 #g/ml), (all from 
Grand Island Biological Co.), 2-mercaptoethanol (5 ×  10  -5 M) (Eastman Kodak Co., Rochester 
N. Y.), hepes buffer (10 mM)  (Microbiological Associates,  Walkersville, Md.), and 7.5% fetal 
calf serum (FCS; Hyclone Laboratories, Logan, Utah). 
Briefly, the technique for cell  culture is as follows:  14 d  after immunization and in some 
instances,  14 d  after boost immunization, femoral and popliteal lymph nodes were removed 
aseptically, teased apart, and separated by grinding between the frosted ends of two sterile 
microscope slides,  followed  by  passage  over sterile  Nitex  (Tetko  Co.,  Elmsford,  N.  Y.)  to 
eliminate solid debris.  After two washings, these lymph node cells were incubated on nylon 
wool adherence columns bathed in media supplemented with 20% F(2S for 60 min at 37°C. 
After this incubation, enriched, antigen-reactive lymph node T lymphocytes (LNL) were eluted 
from the nylon wool columns. Antigen-presenting adherent accessory cells (AA(2) were obtained 
from two sources: spleens  were aseptically removed from the animal donors, single-cell  suspen- 
sions were made, and the spleen cells were allowed to adhere to sterile  glass petri dishes for 2 h. 
Simultaneously, the peritoneal cavities of splenic donor mice were lavaged with heparinized 
HBSS (10 U heparin/ml), and these peritoneal washout cells (PC) were also allowed to adhere 
for 2 h.  Then,  the spleen-adherent  cells  and  adherent  PC cells  were collected as described 
previously and pooled and treated with 40 p.g/ml mitomycin (2 (Sigma Chemical Co.) for 60 
min at 37°(2. These cells were then washed vigorously five times to remove excess mitomycin 
(2 and then were used as accessory cells for T cell proliferation or as targets for antigen pulsing. LANNY J.  ROSENWASSER AND BRIGITTE T.  HUBER  1115 
LNL T  cells, and AAC, with or without antigen were then cultured for 96 h  at densities of 
2 ×  105 LNL T  cells, and 5  ×  104 AAC in 200 #1 complete medium/well in round-bottomed 
microtiter plates (Cooke Engineering Co., Alexandria, Va.) at 37°C with an atmosphere of 5% 
COu  and  95%  air.  During  the final  16-24  h  of culture,  each well was pulsed  with  1 #Ci of 
tritiated thymidine  ([SH]TdR; 6.6 Ci/mM, New England Nuclear, Boston Mass.).  Cells were 
then harvested on glass fiber filter paper by the use of a  microharvesting device (MASH II; 
Microbiological Associates).  [aH]TdR  incorporation was measured and all results reported as 
mean counts per minute SEM  for triplicate determinations  or as Acpm -- number of counts 
above control; e.g., experimental (with antigen) -  control (no antigen). 
The  following method  was  used  to  pulse  beef insulin,  TNP-OVA, or PPD  onto  antigen- 
presenting  AA(2:  Mitomycin  C-treated  AAC  were  incubated  in  complete  medium  with  or 
without  100 #g/ml beef insulin,  100 #g/ml TNP-OVA, or 100 #g/ml PPD at 37°(2 for 60 min 
at a  concentration of 1 ×  10s-5 ×  10  ° AA(2/ml. After this, AA(2 were washed thoroughly five 
times to remove excess antigen  and  then readjusted  to the appropriate  cell concentration  in 
complete medium. 5 ×  104 antigen- or media-pulsed AA(2 were then added to 2 ×  105 primed 
LNL T  cells/well, cultured  for 4  d  as outlined above and  proliferative activity measured  by 
[SH]TdR uptake. The data are expressed as Acpm ~  antigen-pulsed AA(2 activation of primed 
LNL T  cells -  media-pulsed AAC activation of primed LNL T  cells. 
Alloantisera.  Anti I-A  b alloantiserum, (A ×  B10.A)F1 anti-B10.A(5R) was obtained from the 
Research Resource Branch, National Institute of Allergy and Infectious Diseases, and its anti- 
K b activity was absorbed with El-4 tumor cells. Anti-Ia.W39 was prepared by immunizing (N 
×  Bo)F1 male mice with B6 spleen cells, as previously described (10). Normal mouse sera (NMS) 
from nonimmune male (N ×  B6)Fa mice was used as a  control. 
Blocking Experiments.  To assess the blocking effect of antisera,  1% NMS, conventional anti- 
I-A  b, or anti-Ia.W39 were added  at the start  of culture and were present  continuously in the 
cultures. 
Results 
Effect of Anti-Is Sera on the Insulin-specific  T  Cell Proliferative Response.  To  ascertain 
the functional role of Ia.W39 on antigen-presenting M,k, we tested the ability of anti- 
Ia.W39 serum to block insulin-specific T  cell proliferation in B6 mice. As can be seen 
TABLE  I 
Effect of Anti-Is Sera on Proliferative Responses of B6 T Cells* 
Beef insulin (100/zg/ml)  PPD (10 #g/ml) 
[SH]TdR  Percent  [SH]TdR  Percent 
incorporation~  inhibition§  incorporation  inhibition 
Acpm  Acpm 
Experiment 1 
I% NMS  11,901  --  10,055  -- 
I% anti-Ia.W39  1,287  89  3,786  62 
Experiment 2 
1% NMS  22,509  --  8,229  -- 
1% anti-LA  b  2,580  89  0  100 
* 2  ×  105  LNL T  cells,  5  ×  104  AAC/well cultured  for 4  d  in  round-bottomed 
microtiter plates. 
:~ Acpam =  experimental (with antigen) -  control (without antigen); baseline control 
=  [ H]TdR incorporation of LNL and AAC without antigen: experiment ! =  1,152 
+  815 cpm, experiment 2 ~= 2,115 4- 234 cpm. 
Acpm anti-Ia~ 
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TABLE  II 
Effect of Anti-Ia Sera on Proliferative Response of lmmune (N ×  B6)Ft 
Female T Cells to Beef Insulin* 
[aH]TdR incorporation:]:  Percent inhibition§ 
~cpm 
Experiment 1 
1% NMS  4,885  -- 
I% anti-Ia.W39  1,318  73 
1% anti-I-A  b  504  90 
Experiment 2 
1% NMS  5,156  -- 
1% anti-Ia.W39  1,246  76 
1% anti-LA  b  0  100 
The proliferative technique was the same as in Table I. 
* Beef insulin, 100 #g/ml for in vitro challenge. 
1: Acpm =  ex~rimental (with antigen) -  control (without antigen); baseline 
control =~ [ H]TdR incorporation of LNL and AAC without antigen: exper- 
iment 1 -- 567 +  103 cpm, experiment 2 =  259 :t= 86 cpm. 
Acpm anti-la.~ 
§ Percent inhibition =  1  Acpm NMS ]  ×  100. 
TABLE  III 
Effect of Anti-la  Sera on Proliferative Responses of Pork Insulin-immune BDF1 T 
Cells 
[SH]TdR incorporation* 
Pork insulin  Beef insulin  TNP-OVA 
(100 #g/ml)  (100 #g/ml)  (200 #g/ml) 
Percent 
inhibition~: 
~cpm 
Experiment 1 
1% NMS  8,700  7,287  74,208  -- 
1% anti-Ia.W39  7,248  6,583  41,279  44 
1% anti-LA  b  7,862  6,444  42,440  42 
Experiment 2 
1% NMS  5,679  6,694  34,667  -- 
1% anti-Ia.W39  6,435  5,979  23,066  33 
1% anti-LA  b  5,972  5,336  18,769  45 
The proliferative technique was the same as in Table I. 
* Aepm ------  experimental (with antigen) -  control (without antigen); baseline control 
-- [*H]TdR incorporation of LNL and AAC without antigen: experiment 1 ~  1,821 
:t: 807 cpm, experiment 2 ~  573 :k 84 cpm. 
~cpm anti-Ia~ 
:~ Percent inhibition -  1 -  Acpm NMS ,/  ×  100 for TNP-OVA. 
in  Table  I,  experiment  1,  1%  anti-Ia.W39  serum  markedly  inhibited  beef  insulin- 
induced  proliferation  (89%)  and,  to  a  lesser, extent  PPD-induced  cell  division  (62%). 
Anti-I-A b serum  also significantly  blocked  both  beef insulin-  (89%)  and  PPD-  (100%) 
induced  activation.  The  same  results were  obtained  using  (N  ×  B6)F1  female  T  cells LANNY J.  ROSENWASSER AND BRIGITTE T.  HUBER 
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Proliferative Response of lmmune F~ T  Cells 
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[aH]TdR incorporation* 
(N ×  B6)F~ <2  (N ×  B6)F~ d  (B6 ×  N)F] d 
(Acpm ± SEM)  ×  10 -s 
Beef insulin (100 pg/ml)  12.28 ±  2.74  2.30 ± 0.69  17.45 ±  1.84:1: 
Pork insulin  (100 pg/ml)  2.51 ±  0.91  1.33 ±  0.47  2.64 ±  1.32 
TNP-OVA (200 pg/ml)  49.68 ±  3.73  42.08:1:5.69  ND§ 
PPD (10 #g/ml)  6.98 ±  1.10  4.91 4- 1.29  7.58 4- 2.72 
PHA (1 #g/ml)  63.96 ±  16.39  48,05 ±  10.55  39.55 ±  4.03 
The proliferative technique was the same as in Table I. 
* Mean  (Aepm  ±  SEM)  ×  10  -s for four experiments. Acpm ffi experimental (with 
antigen) -  control (no antigen); control -  spontaneous incorporation of [SH]TdR 
in cultures of AAC and LNL T cells without antigen: control baselines:  (N × B6)F1 
<2:3.45 ±  1.16, (N ×  B6)F~ d: 3.37 ±  1.66, (B6 ×  N)F~ d: 2.12 4- 1.19. 
:it: Mean (Acpm ±  SEM) ×  10  -2 for three experiments. 
§ Not done. 
TABLE  V 
Response of lmmune  (N ×  B6)F1 Female T Cells to Antigen-pulsed 
Adherent Presenting Cells* 
Antigen-pulsed Mq~ (AAC)  [~H]TdR incorporation§ 
(Acpm ±  SEM)  X  10 -a 
Fl <2 Beef insulin  11.09 ± 0.58 
Fa <2 PPD  15.10 ±  1.94 
F1 <2 TNP-OVA  24.28 ±  2.65 
F1 d Beef insulin  1.77 ±  0.62 
F1 d PPD  6.68 ± 0.23 
Fl C~ TNP-OVA  19.32 -1- 1.51 
* 5 ×  104 M~b (AAC)  ±  antigen pulse mixed with 2 ×  105 LNL T  cells/well 
cultured for 4 d in round-bottomed microtiter plates. 
:~ Mck (AAC) -pulsed with 100 p,g/ml beef insulin or 100 p,g/ml PPD in some 
instances,  as outlined in Materials and Methods. 
§ Acpm ffi antigen-pulsed M~b activation of LNL T cells -  media-pulsed Mob 
activation of LNL T  cells. Baseline:  spontaneous incorporation of [ZH]TdR 
in culture of M~k (AAC)  and  LNL T  cells without antigen pulse (Acpm). 
Control baseline:  F] <2 AAC: 2.94 ±  0.15;  Fl <5' AAC: 2.36 ±  0.55;  mean 
(Acpm ±  SEM) ×  10  -a for three experiments. 
for proliferation  (Table  II, experiments  1 and  2);  namely,  anti-Ia.W39  and  anti-I-A  b 
sera caused  a  75 and 95%  inhibition of beef insulin-induced  activation, respectively. 
As  a  specificity  control  for  the  activity  of anti-Is.W39  and  anti-I-A  usera,  BDF1 
mice were primed with pork insulin and TNP-OVA  (Table III). Only the DBA/2  (H- 
2 a)  parent  of BDF1  mice can  respond  to  the antigenic  determinants  in  pork  insulin 
which are on the B  chain.  Because the B  chains of beef and pork insulin are identical, 
there is a  complete cross-reaction between beef and pork insulin in the H-2  a haplotype. 
As can  be seen  in  Table  III,  BDFx  mice made  equal  proliferative  responses  to  beef 
and  pork  insulin,  and  moreover these  responses  were unaffected  by  the  addition  of 
anti-Ia.W39 and anti-I-A  b sera.  However, both antisera reduced the response of BDF~ 1118  X-LINKED REGULATION OF Ir GENE FUNCTION 
TABLE  VI 
Response of Immune Adult (N × B6)F1 Female T Cells to Antigen-pulsed 
Adherent Presenting Cells* 
Antigen-pulsed Mq~ (AAC):~  [SH]TdR incorporation§ 
Acpm 
Adult F1 ~ beef insulin  9,064 
Adult Fl ~ TNP-OVA  20,339 
Neonatal Fx ~ beef insulin  0 
Neonatal F] ~ TNP-OVA  21,753 
* Usual proliferative technique as described in Table V. Results of one typical 
experiment out of three are shown here. 
:]: Acpm -- antigen-pulsed M~ activation of LNL T cells -  media-pulsed Mq~ 
activation of LNL T cells, baseline control: spontaneous incorporation of 
[SH]TdR in cultures of M~k (AAC) and LNL T cells without antigen pulse 
(cpm). Control baseline: adult F] 9 Mck (AAC): 1,157 4- 398, neonatal F1 
M~ (AAC):  883 4- 243. 
§ M~ (AAC) -pulsed with 100 #g/ml beef insulin or 200 #g/mI. TNP-OVA in 
some instances, as outlined in Materials and Methods. 
[[ Neonatal Mq~ (AAC) prepared as described in Materials and Methods from 
mice that were 8-d old. 
mice  to  TNP-OVA,  suggesting  that  at  least  some  TNP-OVA  response  may  be 
associated with Ia.W39. 
Immune Proliferative Response of Normal and xid-defective F1 Mice to Beef  Insulin.  A series 
of experiments is summarized in Table IV that depict the comparative ability of beef 
insulin-primed T  cells  from normal  (N ×  B6)F1  female and  (B6  ×  N)F1  male mice 
and from defective (N ×  B6)F1  male mice to respond to beef and pork insulin and 
other  immunogens.  Both  normal  female  (N  ×  B6)F1  and  male  (B6  ×  N)F]  mice 
mounted good T  cell responses to beef insulin with very little cross-reaction to pork 
insulin stimulation (indicative of H-2  b type recognition of the A chain loop determi- 
nant within beef insulin).  The xid-defective male (N ×  B6)F1  mice, however, could 
not develop a significant primed T cell proliferative response to beef insulin. All three 
groups of mice made comparable responses to TNP-OVA, PPD, and PHA. Because 
the defective F1 male mice express all conventional Iab specificities but lack Ia.W39, 
the striking conclusion offered by these data is that beef insulin responsiveness in the 
H-2  b mouse is associated with the expression of Ia.W39. 
Response of  Immune F1 Female T Cells to Antigen-pulsed Presenting Cells.  To test potential 
cellular defects in the beef insulin response of (N ×  B6)Ft male mice, we compared 
the ability of antigen  (beef insulin  or PPD)  -pulsed Mq) from xid defective F1 male 
and normal Ft female mice to activate syngeneic FI female T  cells, which are immune 
to beef insulin and CFA. As is shown in Table V, the FI female Mq~ presented beef 
insulin to the immune T cells, whereas the F1 male M~, pulsed with beef insulin, were 
unable to induce proliferation in the same group of T  cells.  Although a T  cell defect 
cannot be ruled out, these data imply that the xid-associated unresponsiveness to beef 
insulin is at the level of the antigen-presenting cell, which lacks Ia.W39 determinants. 
In controls included in Table V, both male and female F1 Mq~, pulsed with PPD and 
TNP-OVA, activated the primed T  cells significantly, although the  FI female Mq) 
were slightly more efficient  than  the F1 male.  Although this difference may not be 
statistically  significant,  it  may  imply  that  some  degree  of PPD  and  TNP-OVA 
responsiveness in the H-2  b haplotype is also associated with Ia.W39. LANNY J.  ROSENWASSER  AND  BRIGITTE T.  HUBER  1119 
Ontogeny of Presenting Cell Competence  for Beef Insulin Is Ia. W39 Related.  Expression of 
Ia.W39  on  the  B  cell  membrane  is  not  evident  until  21  d  after  birth,  whereas 
conventional Ia  is  present  on  B  cells  from neonatal  mice.  With  this  in  mind,  we 
compared the ability of M¢~ from neonatal  (8 d  old)  and adult  (N ×  B6)F1 female 
mice to present beef insulin to adult primed syngeneic T  cells. As can be seen in one 
typical  experiment  out  of a  total  of three  in  Table  VI,  the  neonatal  M~  were 
specifically deficient in presenting beef insulin, although they presented TNP-OVA 
efficiently. The adult Mq~ were able to present both antigens. These results highlight 
once again the association of Ia.W39 with beef insulin responsiveness at the level of 
the antigen-presenting Mq~. 
Discussion 
Our understanding of the I region of the MHC has increased through the functional 
and genetic analysis of recombinant mice and by serological and structural definition 
of the Ia antigens  (13-15).  However, progress has been considerably slower in  the 
study of the mechanism, cellular site of action, and regulation of expression of Ir gene 
function. 
The  experiments  in  this  report  have  unequivocally shown,  using  different  ap- 
proaches, that the responsiveness to beef insulin in the H-2  b haplotype is dependent 
on the expression of Ia.W39 on antigen-presenting Mq~. Moreover, we have demon- 
strated  for the  first  time a  non-MHC  gene  (xid) -linked  regulation  of an  Ir gene 
function. 
Mutant CBA/N mice possess on X-linked recessive defect, which has been recently 
mapped (xid) (16). This xid gene regulates the expression of the late-appearing B cell 
differentiation antigens  Lyb-3 (17), Lyb-5 (18), Lyb-7 (19), and  the newly defined 
Ia.W39  (10). As this latter alloantigen is encoded by the I-A  b subregion of the H-2 
gene complex, it seemed reasonable to ask two questions about its function: First, is 
Ia.W39 expressed functionally by antigen-presenting M~? Second, what is the rela- 
tionship of Ia.W39 to I-Ab-linked Ir gene function? The response of H-2  b mice to beef 
insulin represented an ideal situation to analyze these two questions. 
We  have shown  that  monospecific anti-Ia.W39  serum  could block beef insulin- 
induced T  cell proliferation in  H-2  b mice.  The conventional anti-I-A  b serum  also 
blocked beef insulin-induced T cell proliferation; however, it should be noted that the 
anti-I-A  b antisera  may contain  anti-Ia.W39  antibodies.  This  is  a  likely possibility, 
because it was found in immunoprecipitation experiments that anti-I-A  b serum could 
preclear Ia.W39, but not vice versa.  2 Over the years, on the basis of multiple studies 
in both mice and guinea pigs, it has been implied that alloantisera blockade is at the 
level of the antigen-presenting M~, although no data absolutely prove this point (20, 
21).  More  recent  experiments  utilizing  monoclonal  antibodies  and  parent  --*  F1 
chimeras  as  a  source of lymphoid cells reconfirm  the  suspicion  that  inhibition  of 
response by anti-Ia reagents occurs at the level of the antigen-presenting accessory cell 
(23).  It  therefore follows  from  these  blocking  experiments  that  Ia.W39,  a  B  cell 
differentiation marker expressed an a  subpopulation of B  cells, is also functionally 
expressed by antigen-presenting Mq~. 
With  a  different  approach,  we  have  shown  that  beef insulin  responsiveness  is 
associated with the expression of Ia.W39, by demonstrating that normal (N ×  B6)F1 
female and  (B6 ×  N)F1 male mice as opposed to defective (N  ×  B6)F1 male mice 1120  X-LINKED REGULATION OF Ir GENE FUNCTION 
could mount a T cell proliferative response to beef insulin. The same pattern was seen 
in the secondary IgG plaque-forming cell (PFC) response to beef insulin, measured in 
these groups of mice (B. T. Huber and L. J. Rosenwasser, manuscript in preparation). 
Furthermore, we have shown that defective F1 male M~ cannot present beef insulin 
to responder F1 female beef insulin-primed T  cells. 
In sum, we have found in (N ×  B6)F1 male mice a defect in insulin-related Ir gene 
function and expression of Ia.W39 on antigen presenting Mth. In the xid defective (N 
×  B6)F1 male B cells, it is felt that lack of Ia.W39 represents a  maturation arrest in 
the differentiation pathway, whereby certain subsets of B  cells do not develop. By 
analogy, the mechanism ofxid-regulated defective Ir gene function may be a result of 
deletion  or  faulty  maturation  of a  subpopulation  of  antigen-presenting  Mth  or 
alternatively, a  selective defect in Ia.W39 expression on the Mth membrane may be 
evident on all Ia-bearing Mth. Experiments to assess those possibilities are in progress. 
Additionally, T  cell proliferation experiments in (N ×  B6)F1 males and females with 
beef  collagen and poly(L-Tyr, L-Glu)-poly(DL-Ala)-poly(L-Lys);  both under the control 
of genes located in the I-A  b subregion are in progress, to see if these responses are also 
dependent on expression of Ia.W39. The molecular mechanism of this xid-regulated 
Ir gene deficit is unknown and  investigation in this area may provide a  key to the 
precise workings of Ir genes. Another point of interest that is immediately apparent 
is  whether  this xid regulatory gene  is  operative  in  other  haplotypes  as  a  general 
regulatory phenomenon;  and for that  reason, experiments examining the insulin  B 
chain determinant responses in (N X BALB)F1 males and females are in progress. (H- 
2  d mice recognize a determinant in the B chain of insulin, whereas H-2  b mice recognize 
a determinant in the A chain loop). 
Two further points should be made concerning the results reported here. First, the 
data in this paper highlight  the strong assocation of the Ia.W39 specificity with Ir 
gene function for beef insulin in H-2  b mice. Other examples of the association of Ia 
antigens with Ir gene functions have been documented in previous studies  in both 
guinea  pigs  and  mice  (23,  24).  More  recently, work with  a  monoclonal antibody 
directed against Ia antigens containing the combinatorial determinant A~b'k'~'~-E~ has 
shown a clear association of these hybrid Ia antigens with Ir gene function for pigeon 
cytochrome c in B10.A mice and  for poly(Glu, Lys, Phe)  9 in B10.A(SR)  mice (25). 
Second, the findings of this report document for the first time a potential Mth defect 
associated with mutant CBA/N mice. These mice make defective responses to thymus- 
independent type 2 (TI-2) antigens such as TNP-FicolI; Boswell et al. (26) have shown 
that the in vitro response of B cells to thymus-independent type 2 (TI-2) antigens is 
M~ dependent, however, those same workers felt that the defect in CBA/N mice to 
TI-2 antigens rested with a lack of the Lyb-5  + subset of B cells and that CBA/N Mq~ 
could present TI-2 antigens to an appropriate B cell (27). 
Finally, we have shown that neonatal, antigen-presenting Mt~, which presumably 
do  not  acquire  Ia.W39  until  21  d  after birth  but  have  conventional  Ia  antigens 
analogous to neonatal B cells, are deficient in presenting beef insulin to primed adult 
T  cells, again suggesting the association of Ia.W39 with beef insulin responsiveness at 
the level of the Mdp. Recently Nadler et al.  (28)  showed that  neonatal (<14 d  old) 
antigen presenting M~ are incompetent at inducing in vitro primary TNP-KLH PFC 
responses and  Lu et al.  (29)  showed that  neonatal  M~ are deficient at  presenting 
Listeria monocytogents antigen to immune T  cells.  Our findings on the incompetency of LANNY J.  ROSENWASSER AND BRIGITTE T.  HUBER  1121 
normal neonatal Mck to present insulin to primed, adult T  cells is in accord with those 
studies. However, wo do not find a generalized defect in Ia-dependent T cell activation 
in  neonatal  M~,  because  they  can  present  TNP-OVA  to  immune  T  cells.  It  is 
reasonable to infer from our studies that neonatal Mq~ acquire the ability to present 
insulin as they acquire Ia.W39; therefore, it may be likely that functional maturation 
and acquisition of Ia.W39 and perhaps all Ia antigens by antigen-presenting Mqb may 
be under the influence of the X-linked regulatory gene(s). 
Thus we have shown that beef insulin responsiveness in the H-2  b mouse is dependent 
on the expression of Ia.W39  by antigen-presenting  Mqb. The  defect  in  beef insulin 
reactivity in mutant (N ×  B6)Fx male mice is a result of lack of expression of Ia.W39, 
regulated by the xid gene. The discovery of an X-linked regulatory gene for Ir gene 
function  is a  new and  provocative finding and should  provide the basis  for future 
studies on the regulation and mechanism of antigen responsiveness. 
Summary 
Immune response (Ir) genes are encoded for by the I region of the major histocom- 
patibility complex (MHC). A class of serologically defined specificities, Ia antigens, is 
also encoded for by genes within this region. A new Ia specificity, Ia.W39, has recently 
been defined. It is private for I-A  b and its expression is controlled by a gene on the X- 
chromosome. Using different approaches, the role of Ia.W39 in the immune response 
of  H-2  b  mice  to  beef insulin  was  examined  in  a  macrophage-dependent  T  cell 
proliferation  assay.  It  was  found  that  beef insulin-related  Ir  gene  function  was 
associated with the expression of Ia.W39 by antigen-presenting macrophages and that 
control of this Ir gene function was X-linked (xid gene). 
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